UBS Begins Dallah Healthcare's Coverage at Neutral

08:34 AM EDT, 07/16/2026 (MT Newswires) -- UBS on Thursday started its coverage of healthcare company Dallah Healthcare (SASE:4004) with a neutral rating and a price target of 116.00 Saudi riyals. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)